BMI View: Egypt's pharmaceutical and healthcare sector presents a high-risk investment opportunity for
international drugmakers. The North African country continues to attract a significant deal of attention
from multinational pharmaceutical companies looking to take ..."
BMI View: Egypt's evolving demographic and epidemiological profile will support pharmaceutical growth
over the long-term. The Egyptian government's commitment to healthcare has been demonstrated through
significant increases to national budget allocations for the heal ..."
BMI View: Egypt's universal health coverage implementation will face delays in its roll-out given the
government's poor track record of healthcare policy implementation. Questions regarding financial
feasibility will also be raised; however, we note that the governmen ..."
BMI View: Egypt's pharmaceutical market presents one of the most attractive investment destinations for
multinational drugmakers in the MENA region. A large market size and population, coupled with an
improved political and economic outlook, support our positive outlo ..."
BMI View: The positive outlook for Egypt's pharmaceutical market has been reinforced, with access to
medicines increasing through enhancing health insurance uptake and a greater interest among foreign
pharmaceutical companies. This represents an impressive turnaround, ..."
BMI View: Egypt's inclusion on PhRMA's Special 301 Submission for the second year running highlights
that regulatory approval delays and a restrictive pricing policy are still issues being faced by innovative
drugmakers operating in the country. The domestic productio ..."
BMI View: Recent developments have led us to hold a more positive outlook for Egypt's pharmaceutical
and healthcare markets. An increased healthcare budget for 2015, combined with the government's efforts
at developing the local manufacturing industry and combating medicine sho ..."
BMI View: Egypt's relative political stability will lead to a pickup in growth over the coming quarters,
increasing the attractiveness of the pharmaceutical market - for which our forecast has been revised slightly
upwards. The government's increased emphasis on developing the ..."
BMI View: The landslide victory by Abdel Fattah al-Sisi in the presidential election in Egypt increases the
attractiveness of the country's pharmaceutical market, which has been deteriorating for the past few years.
Key challenges facing multinational companies includ ..."
BMI View: This quarter has seen a number of developments that indicate an increasingly difficult
operating environment for local and foreign drugmakers in Egypt. These include suspension of some local
drug production, ongoing strikes by doctors and calls for improveme ..."